CVD is the leading cause of death in the US. Hypertension and diabetes are among the foremost risk factors for the development of CVD, stroke, peripheral artery disease, and heart attack. This program will provide an overview of recent advances that target the underlying pathophysiology of cardiovascular disease. The focus of the program will be on the new guidelines for hypertension, DM and CKD and will discuss the advances in pharmacotherapeutics in these fields.

Glomerular disease is associated with morbidity and mortality in patients of all ages and is a common cause of end stage kidney disease. These include those that commonly present with nephrotic syndrome (minimal change disease, FSGS and membranous nephropathy), the nephrotic syndrome (vasculitis, lupus nephritis and IgA nephropathy), among others. Treatment often utilizes immunosuppressive regimens such as high dose corticosteroids, alkylating agents, calcineurin inhibitors, biologics and anti...

In the last few years, there has been dramatic advancement in the diagnostic tools and treatment options available for neuromuscular disorders. While this is a welcome development, it may be challenging for neurologists taking care of patients with neuromuscular disorders to keep up to date with all of these advances. The purpose of the Penn Neuromuscular Symposium is to provide both a basic approach to patients with neuromuscular disorders and an update on novel therapeutic agents and future di...

The list of course topics and subtopics was adapted from the ABPN’s description of the board and recertification examinations. The time allotted for each topic is based upon the approximate distribution of the subject matter as given by the ABPN. Our course will provide an excellent review of board exam and recertification topics primarily through case-based learning and help the learner identify areas that require further study. The learner can then review and prepare further in these areas pri...

Preliminary outcomes of the new UNOS kidney allocation policy will be reviewed as well as unintended outcomes that are impacting patients in the greater Philadelphia region. The evolution of the allocation policies will be discussed. Effective strategies to decrease waiting time will be highlighted.

This will be a half day medical education course designed to empower clinician educators with new skills focusing on coaching and using innovative assessment mechanisms that are applicable to any specialty. It will also be a forum to build the clinician educator community, troubleshoot educational challenges, and collaborate on new projects.This activity is designed for Physicians only.

During the course, Rachel Brandstadter, MD and Christopher Perrone, MD will review their recent work in MS management. Dr. Brandstadter will speak to her work in women’s health, specifically as it pertains to MS diagnosis in childbearing years and family planning. Dr. Perrone will discuss treatment best practices and clinical management for MS patients during the COVID-19 era.Dina Jacobs, MD and Amit Bar-Or, MD, FRCPC will serve as featured moderators for the Q&A portion of the course. Drs. ...

During the activity, the presenters will review two neurology cases, as well as two surgical epilepsy cases. Each case will be specific to the treatment of adult patients with epilepsy, whose diseases have been resistant to medication. The four cases will provide a review of current medical and surgical practices and will highlight technological advances in monitoring and treating seizures and epilepsy.Following the case discussion, Drs. Davis and Gelfand will review the qualifications and proce...

Live panel discussion featuring pancreatic cancer experts from medical oncology, surgery, radiation oncology, nurse navigation and translational research from Penn Medicine.  Moderated by Ursina Teitelbaum, MD, the team will provide updates in the coordinated care approach to this complex disease, including clinical trial navigation, surgical updates to minimally invasive and locally advanced procedures, perioperative therapy for pancreatic cancer and more.

The Rheumatology Open Online Curriculum for Rheumatology and Dermatology Healthcare Providers: A Unique Initiative to Improve Outcomes for Patients with Inflammatory Rheumatic Diseases at Risk for COVID-19.Globally, there are still nearly 10,000 deaths daily from the coronavirus and more than 600,000 in the U.S. during the pandemic.  Despite the advent of vaccines, accompanied by a dramatic decrease in incidence in some nations, the disease continues to surge worldwide.  Newer...